39 results on '"Kinase activity"'
Search Results
2. Exploring Protein Kinase CK2 Substrate Recognition and the Dynamic Response of Substrate Phosphorylation to Kinase Modulation.
- Author
-
Cesaro, Luca, Zuliani, Angelica Maria, Bosello Travain, Valentina, and Salvi, Mauro
- Subjects
- *
PROTEIN kinase CK2 , *PHOSPHORYLATION , *KINASES , *PROTEIN kinases - Abstract
Protein kinase CK2 (formerly known as casein kinase 2 or II), a ubiquitous and constitutively active enzyme, is widely recognized as one of the most pleiotropic serine/threonine kinases. It plays a critical role in numerous signaling pathways, with hundreds of bona fide substrates. However, despite considerable research efforts, our understanding of the entire CK2 substratome and its functional associations with the majority of these substrates is far from being completely deciphered. In this context, we aim to provide an overview of how CK2 recognizes its substrates. We will discuss the pros and cons of the existing methods to manipulate CK2 activity in cells, as well as exploring the dynamic response of substrate phosphorylation to CK2 modulation. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. ALPK3 Functions as a Pseudokinase.
- Author
-
Feng, Wei, Bogomolovas, Julius, Wang, Li, Li, Mengchen, and Chen, Ju
- Subjects
- *
CARDIOMYOPATHIES , *PHOSPHORYLATION , *CRISPRS , *GENES , *MICE - Abstract
The article discusses the ALPK3 gene and its potential role in cardiomyopathies. While there are conflicting findings regarding ALPK3's kinase activity, recent studies suggest that ALPK3 functions as a pseudokinase rather than a true kinase. The article presents evidence from in vitro and in vivo experiments, including an in vitro phosphorylation assay and the generation of knock-in mice with a mutated ALPK3 gene. These findings suggest that ALPK3 variants associated with cardiomyopathy may affect other aspects of the protein rather than its kinase activity. [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
4. How can a traffic light properly work if it is always green? The paradox of CK2 signaling.
- Author
-
Borgo, Christian, D'Amore, Claudio, Cesaro, Luca, Sarno, Stefania, Pinna, Lorenzo A., Ruzzene, Maria, and Salvi, Mauro
- Subjects
- *
PROTEIN kinase CK2 , *PROTEIN kinases , *ENZYME regulation , *PHOSPHORYLATION , *VIRUS diseases - Abstract
CK2 is a constitutively active protein kinase that assuring a constant level of phosphorylation to its numerous substrates supports many of the most important biological functions. Nevertheless, its activity has to be controlled and adjusted in order to cope with the varying needs of a cell, and several examples of a fine-tune regulation of its activity have been described. More importantly, aberrant regulation of this enzyme may have pathological consequences, e.g. in cancer, chronic inflammation, neurodegeneration, and viral infection. Our review aims at summarizing our current knowledge about CK2 regulation. In the first part, we have considered the most important stimuli shown to affect protein kinase CK2 activity/expression. In the second part, we focus on the molecular mechanisms by which CK2 can be regulated, discussing controversial aspects and future perspectives. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
5. Phosphoproteomics: a valuable tool for uncovering molecular signaling in cancer cells.
- Author
-
Gerritsen, Jacqueline S. and White, Forest M.
- Abstract
Many pathologies, including cancer, have been associated with aberrant phosphorylation-mediated signaling networks that drive altered cell proliferation, migration, metabolic regulation, and can lead to systemic inflammation. Phosphoproteomics, the large-scale analysis of protein phosphorylation sites, has emerged as a powerful tool to define signaling network regulation and dysregulation in normal and pathological conditions. We provide an overview of methodology for global phosphoproteomics as well as enrichment of specific subsets of the phosphoproteome, including phosphotyrosine and phospho-motif enrichment of kinase substrates. We review quantitative methods, advantages and limitations of different mass spectrometry acquisition formats, and computational approaches to extract biological insight from phosphoproteomics data. Throughout, we discuss various applications and their challenges in implementation. Over the past 20 years the field of phosphoproteomics has advanced to enable deep biological and clinical insight through the quantitative analysis of signaling networks. Future areas of development include Clinical Laboratory Improvement Amendments (CLIA)-approved methods for analysis of clinical samples, continued improvements in sensitivity to enable analysis of small numbers of rare cells and tissue microarrays, and computational methods to integrate data resulting from multiple systems-level quantitative analytical methods. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
6. Inference of kinase-signaling networks in human myeloid cell line models by Phosphoproteomics using kinase activity enrichment analysis (KAEA).
- Author
-
Hallal, Mahmoud, Braga-Lagache, Sophie, Jankovic, Jovana, Simillion, Cedric, Bruggmann, Rémy, Uldry, Anne-Christine, Allam, Ramanjaneyulu, Heller, Manfred, and Bonadies, Nicolas
- Subjects
- *
MYELOID cells , *NILOTINIB , *CELL lines , *TANDEM mass spectrometry , *TREATMENT failure , *GENETIC mutation , *PROTEIN kinase inhibitors , *PROTEOMICS , *RESEARCH funding , *PHOSPHORYLATION - Abstract
Background: Despite the introduction of targeted therapies, most patients with myeloid malignancies will not be cured and progress. Genomics is useful to elucidate the mutational landscape but remains limited in the prediction of therapeutic outcome and identification of targets for resistance. Dysregulation of phosphorylation-based signaling pathways is a hallmark of cancer, and therefore, kinase-inhibitors are playing an increasingly important role as targeted treatments. Untargeted phosphoproteomics analysis pipelines have been published but show limitations in inferring kinase-activities and identifying potential biomarkers of response and resistance.Methods: We developed a phosphoproteomics workflow based on titanium dioxide phosphopeptide enrichment with subsequent analysis by liquid chromatography tandem mass spectrometry (LC-MS). We applied a novel Kinase-Activity Enrichment Analysis (KAEA) pipeline on differential phosphoproteomics profiles, which is based on the recently published SetRank enrichment algorithm with reduced false positive rates. Kinase activities were inferred by this algorithm using an extensive reference database comprising five experimentally validated kinase-substrate meta-databases complemented with the NetworKIN in-silico prediction tool. For the proof of concept, we used human myeloid cell lines (K562, NB4, THP1, OCI-AML3, MOLM13 and MV4-11) with known oncogenic drivers and exposed them to clinically established kinase-inhibitors.Results: Biologically meaningful over- and under-active kinases were identified by KAEA in the unperturbed human myeloid cell lines (K562, NB4, THP1, OCI-AML3 and MOLM13). To increase the inhibition signal of the driving oncogenic kinases, we exposed the K562 (BCR-ABL1) and MOLM13/MV4-11 (FLT3-ITD) cell lines to either Nilotinib or Midostaurin kinase inhibitors, respectively. We observed correct detection of expected direct (ABL, KIT, SRC) and indirect (MAPK) targets of Nilotinib in K562 as well as indirect (PRKC, MAPK, AKT, RPS6K) targets of Midostaurin in MOLM13/MV4-11, respectively. Moreover, our pipeline was able to characterize unexplored kinase-activities within the corresponding signaling networks.Conclusions: We developed and validated a novel KAEA pipeline for the analysis of differential phosphoproteomics MS profiling data. We provide translational researchers with an improved instrument to characterize the biological behavior of kinases in response or resistance to targeted treatment. Further investigations are warranted to determine the utility of KAEA to characterize mechanisms of disease progression and treatment failure using primary patient samples. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
7. Gel electrophoresis for phosphorylated proteins: a brief introduction.
- Author
-
Rei Noguchi, Yooksil Sin, and Tadashi Kondo
- Subjects
- *
PROTEIN analysis , *PHOSPHORYLATION , *GEL electrophoresis - Abstract
Protein phosphorylation is a key mechanism that regulates cellular physiological functions such as proliferation, migration, cell cycle progression, apoptosis, and differentiation. Aberrations in kinase activity and subsequent dysregulation of protein phosphorylation occur in the process of carcinogenesis and cancer progression and are considered to be therapeutic targets and biomarkers in oncology. Gel electrophoresis has versatile utility in the study of protein phosphorylation. Phosphorylated proteins can be enriched prior to gel electrophoresis, and the proteins separated by gel electrophoresis are visualized by colorimetric methods or western blotting with antibodies, which specifically detect phosphorylation. Phosphorylated proteins migrate differently from non-phosphorylated proteins in gels containing substrates with affinity for phosphorylation. All these methods can be combined in multiple ways, generating unique data from different viewpoints. The identification of separated proteins can be achieved by mass spectrometry, making it possible to integrate protein and genetic data. Peptide array allow the evaluation of kinase activity in heterogeneous samples. As protein phosphorylation and kinase activity are under the regulation of multiple mechanisms and their statuses influence the structures and functions of the other proteins, a multidisciplinary approach is required, and gel electrophoresis will play an important role in the study of protein phosphorylation. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
8. Phosphoproteome-based kinase activity profiling reveals the critical role of MAP2K2 and PLK1 in neuronal autophagy.
- Author
-
Chen, Lei-Lei, Wang, Yong-Bo, Song, Ju-Xian, Deng, Wan-Kun, Lu, Jia-Hong, Ma, Li-Li, Yang, Chuan-Bin, Li, Min, and Xue, Yu
- Abstract
Recent studies have demonstrated that dysregulation of macroautophagy/autophagy may play a central role in the pathogenesis of neurodegenerative disorders, and the induction of autophagy protects against the toxic insults of aggregate-prone proteins by enhancing their clearance. Thus, autophagy has become a promising therapeutic target against neurodegenerative diseases. In this study, quantitative phosphoproteomic profiling together with a computational analysis was performed to delineate the phosphorylation signaling networks regulated by 2 natural neuroprotective autophagy enhancers, corynoxine (Cory) and corynoxine B (Cory B). To identify key regulators, namely, protein kinases, we developed a novel network-based algorithm ofin silicoKinome Activity Profiling (iKAP) to computationally infer potentially important protein kinases from phosphorylation networks. Using this algorithm, we observed that Cory or Cory B potentially regulated several kinases. We predicted and validated that Cory, but not Cory B, downregulated a well-documented autophagy kinase, RPS6KB1/p70S6K (ribosomal protein S6 kinase, polypeptide 1). We also discovered 2 kinases, MAP2K2/MEK2 (mitogen-activated protein kinase kinase 2) and PLK1 (polo-like kinase 1), to be potentially upregulated by Cory, whereas the siRNA-mediated knockdown ofMap2k2andPlk1significantly inhibited Cory-induced autophagy. Furthermore, Cory promoted the clearance of Alzheimer disease-associated APP (amyloid β [A4] precursor protein) and Parkinson disease-associated SNCA/α-synuclein (synuclein, α) by enhancing autophagy, and these effects were dramatically diminished by the inhibition of the kinase activities of MAP2K2 and PLK1. As a whole, our study not only developed a powerful method for the identification of important regulators from the phosphoproteomic data but also identified the important role of MAP2K2 and PLK1 in neuronal autophagy. [ABSTRACT FROM PUBLISHER]
- Published
- 2017
- Full Text
- View/download PDF
9. Synthesis and Evaluation of 3-(furo[2,3 -b]pyridin-3-yl)-4-(1H-indol-3-yl)-maleimides as Novel GSK-3 β Inhibitors and Anti-Ischemic Agents.
- Author
-
Ye, Qing, Li, Qiu, Zhou, Yubo, Xu, Lei, Mao, Weili, Gao, Yuanxue, Li, Chenhui, Xu, Yuan, Xu, Yazhou, Liao, Hong, Zhang, Luyong, Gao, Jianrong, Li, Jia, and Pang, Tao
- Subjects
- *
MALEIMIDES , *CEREBRAL ischemia , *GLUTAMIC acid , *PHOSPHORYLATION , *GLYCOGEN synthase kinase - Abstract
A series of novel 3-(furo[2,3 -b]pyridin-3-yl)-4-(1H-indol-3-yl)-maleimides were designed, synthesized, and biologically evaluated for their GSK-3 β inhibitory activities. Most compounds showed favorable inhibitory activities against GSK-3 β protein. Among them, compounds 5n, 5o, and 5p significantly reduced GSK-3 β substrate tau phosphorylation at Ser396 in primary neurons, indicating inhibition of cellular GSK-3 β activity. In the in vitro neuronal injury models, compounds 5n, 5o, and 5p prevented neuronal death against glutamate, oxygen-glucose deprivation, and nutrient serum deprivation which are closely associated with cerebral ischemic stroke. In the in vivo cerebral ischemia animal model, compound 5o reduced infarct size by 10% and improved the neurological deficit. The results may provide new insights into the development of novel GSK-3 β inhibitors with potential neuroprotective activity against brain ischemic stroke. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
10. The unique characteristics of HOG pathway MAPKs in the extremely halotolerant Hortaea werneckii.
- Author
-
Kejžar, Anja, Cibic, Matej, Grøtli, Morten, Plemenitaš, Ana, and Lenassi, Metka
- Subjects
- *
MITOGEN-activated protein kinases , *SACCHAROMYCES cerevisiae , *PHOSPHORYLATION , *FUNGAL gene expression , *RECOMBINANT microorganisms ,YEAST physiology - Abstract
HwHog1A/B, Hortaea werneckii homologues of the MAP kinase Hog1 from Saccharomyces cerevisiae, are vital for the extreme halotolerance of H. werneckii. In mesophilic S. cerevisiae, Hog1 is phosphorylated already at low osmolyte concentrations, and regulates expression of a similar set of genes independent of osmolyte type. To understand how HwHog1 kinases activity is regulated in H. werneckii, we studied HwHog1A/B activation in vivo, by following phosphorylation of HwHog1A/B in H. werneckii exposed to various osmolytes, and in vitro, by measuring kinase activities of recombinant HwHog1A, HwHog1B and Hog1ΔC. To this end, highly pure and soluble recombinant Hog1 homologues were isolated from insect cells. Our results demonstrate that HwHog1A/B are, in general, transiently phosphorylated in cells shocked with ≥3 M osmolyte, yet constitutive phosphorylation is observed at extreme NaCl and KCl concentrations. Importantly, phosphorylation profiles differ depending on the osmolyte type. Additionally, phosphorylated recombinant HwHog1A/B show lower specific kinase activities compared to Hog1ΔC. In summary, HOG pathway MAPKs in the extremely halotolerant H. werneckii show unique characteristics compared to S. cerevisiae homologues. The reported findings contribute to defining the key determinants of H. werneckii osmotolerance, which is important for its potential transfer to economically relevant microorganisms and crops. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
11. Synthesis and biological evaluation of 3-([1,2,4]triazolo[4,3-a]pyridin-3-yl)-4-(indol-3-yl)-maleimides as potent, selective GSK-3β inhibitors and neuroprotective agents.
- Author
-
Ye, Qing, Mao, Weili, Zhou, Yubo, Xu, Lei, Li, Qiu, Gao, Yuanxue, Wang, Jing, Li, Chenhui, Xu, Yazhou, Xu, Yuan, Liao, Hong, Zhang, Luyong, Gao, Jianrong, Li, Jia, and Pang, Tao
- Subjects
- *
MALEIMIDES , *NEUROPROTECTIVE agents , *IMIDE synthesis , *GLYCOGEN synthase kinase-3 , *PHOSPHORYLATION , *GLUTAMIC acid - Abstract
A series of novel 3-([1,2,4]triazolo[4,3- a ]pyridin-3-yl)-4-(indol-3-yl)-maleimides were designed, prepared and evaluated for their GSK-3β inhibitory activities. Most compounds showed high potency to GSK-3β inhibition with high selectivity. Among them, compounds 7c , 7f , 7h , 7l and 7m significantly reduced GSK-3β substrate Tau phosphorylation at Ser396 in primary neurons, showing the inhibition of cellular GSK-3β. In the in vitro neuronal injury models, compounds 7c , 7f , 7h , 7l and 7m prevented neuronal death against glutamate, oxygen–glucose deprivation and nutrient serum deprivation which are associated with cerebral ischemic stroke. In the in vivo cerebral ischemia animal model, compound 7f reduced infarct size by 15% and improved the neurological deficit following focal cerebral ischemia. These findings may provide new insights into the development of novel GSK-3β inhibitors with potential neuroprotective activity. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
12. Phosphorylation of cyclin O, a novel cyclin family protein containing a cyclin-like domain, is involved in the activation of cyclin-dependent kinase 2.
- Author
-
DO HYUNG KIM, JONG-HWA PARK, BORA LEE, KYOUNG OK JANG, IN SIK CHUNG, and YE SUN HAN
- Subjects
- *
PHOSPHORYLATION , *CYCLIN-dependent kinases , *CYCLINS , *CELL cycle , *MASS spectrometry - Abstract
Cell cycles, ordered series of events modulating cell growth and division, are tightly regulated by complexes containing cyclin-dependent kinases (CDKs) and cyclins. Cyclin O is a novel cyclin family protein which interacts with CDK2. However, the molecular effects of cyclin O on the activity of CDK2 have not been fully evaluated. In this study, an interaction between cyclin O and CDK2 was identified by co-immunoprecipitation and the effect of cyclin O on the kinase activity of CDK2 was investigated using cyclin O point mutants. Co-immunoprecipitation was achieved using using HEK293 human embryonic kidney cells which were transiently transfected with vectors expressing cyclin O and CDK2, which revealed that cyclin O interacted with CDK2, particularly with the active form of endogenous CDK2. Cyclin O was expressed as several different bands with molecular weights between 45 and 50 kDa, possibly due to different post-translational modifications. When co-expressed with CDK2, cyclin O appeared as a band with a molecular weight of 50 kDa. Treatment with calf intestinal phosphatase reduced the intensity of the uppermost band. Mass spectroscopic analysis of cyclin O co-expressed with CDK2 revealed that the 81st serine residue of cyclin O was phosphorylated. The in vitro kinase activity of CDK2 phosphorylating histone H1 was markedly increased in the cells overexpressing cyclin O. This activity was reduced in cells overexpressing cyclin O, in which the 81st serine had been replaced with alanine (S81A). These results suggest that cyclin O is a novel cyclin family protein that regulates CDK2 kinase activity, which is mediated by the phosphorylation of the 81st serine residue of cyclin O. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
13. Phosphoproteomics-based network medicine.
- Author
-
Liu, Zexian, Wang, Yongbo, and Xue, Yu
- Subjects
- *
PHOSPHOPROTEINS , *PROTEOMICS , *THERAPEUTIC use of biochemical markers , *TARGETED drug delivery , *DIAGNOSIS , *PHOSPHORYLATION , *ANTINEOPLASTIC agents - Abstract
One of the major tasks of phosphoproteomics is providing potential biomarkers for either diagnosis or drug targets in medical applications. Because most complex diseases are due to the actions of multiple genes/proteins, the identification of complex phospho-signatures containing multiple phosphorylation events within phosphoproteomics-based networks generates more efficient and robust biomarkers than a single, differentially phosphorylated substrate or site. Here, we briefly summarize the current efforts and progress in this newly emerging field of phosphoproteomics-based network medicine by reviewing the computational (re)construction of phosphorylation-mediated signaling networks from unannotated phosphoproteomic data, the discovery of robust network phospho-signatures and the application of these signatures for classifying cancers and predicting drug responses. The challenges as well as the potential advantages are evaluated and discussed. Although the current techniques are at present far from mature, we believe that such a systematic approach as we describe can generate more useful and robust biomarkers for biomedical usage, even at the current stage of development. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
14. CDK8 as the STAT1 serine 727 kinase?
- Author
-
Staab, Julia, Herrmann-Lingen, Christoph, and Meyer, Thomas
- Subjects
- *
TYROSINE , *PHOSPHORYLATION , *CYTOKINES , *CHROMATIN , *GENE regulatory networks - Abstract
Whereas cytokine-induced tyrosine phosphorylation of STAT (signal transducer and activator of transcription) proteins by JAK kinases has been well studied, much less is known about STAT-specific serine kinases and their signal-dependent regulation. The paper by Joanna Bancerek and colleagues published recently in Immunity reports that upon interferon-γ (IFNγ) stimulation of cells the chromatin-associated cyclindependent kinase 8 (CDK8) phosphorylates the regulatory serine residue 727 in the transactivation domain of STAT1. The authors state that the CDK8 module of the Mediator complex is a key component in the STAT1 signal pathway, linking serine phosphorylation to genespecific transcriptional events [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
15. Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner.
- Author
-
Akiko Asada, Taro Saito, and Shin-ichi Hisanaga
- Subjects
- *
CYCLIN-dependent kinases regulation , *SUBCELLULAR fractionation , *MYRISTOYLATION , *CELL membranes , *PHOSPHORYLATION , *NEUROPLASTICITY - Abstract
Cdk5 is a member of the cyclin-dependent kinase (Cdk) family, which is activated by neuronal activators p35 or p39. Cdk5 regulates a variety of neuronal activities including migration, synaptic activity and neuronal death. p35 and p39 impart cytoplasmic membrane association of p35-Cdk5 and p39-Cdk5, respectively, through their myristoylation, but it is not clearly understood how the cellular localization is related to different functions. We investigated the role of Cdk5 activity in the subcellular localization of p35-Cdk5 and p39-Cdk5. Cdk5 activity affected the localization of p35-Cdk5 and p39-Cdk5 through phosphorylation of p35 or p39. Using unphosphorylated or phosphomimetic mutants of p35 and p39, we found that phosphorylation at Ser8, common to p35 and p39, by Cdk5 regulated the cytoplasmic localization and perinuclear accumulation of unphosphorylated S8A mutants, and whole cytoplasmic distribution of phosphomimetic S8E mutants. Cdk5 activity was necessary to retain Cdk5-activator complexes in the cytoplasm. Nevertheless, small but distinct amounts of p35 and p39 were detected in the nucleus. In particular, nuclear p35 and p39 were increased when the Cdk5 activity was inhibited. p39 had a greater propensity to accumulate in the nucleus than p35, and phosphorylation at Thr84, specific to p39, regulated the potential nuclear localization activity of the Lys cluster in p39. These results suggest that the subcellular localization of the Cdk5-activator complexes is determined by its kinase activity, and also implicate a role for p39-Cdk5 in the nucleus. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
16. Phosphorylated mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 may not always represent its kinase activity in a rat model of focal cerebral ischemia with or without ischemic preconditioning
- Author
-
Takahashi, T., Steinberg, G.K., and Zhao, H.
- Subjects
- *
MITOGEN-activated protein kinases , *PHOSPHORYLATION , *EXTRACELLULAR signal-regulated kinases , *LABORATORY rats , *ENZYME kinetics , *CEREBRAL ischemia , *CEREBRAL arteries , *ARTERIAL occlusions - Abstract
Abstract: The extracellular signal-regulated kinase (ERK) 1/2 protein requires a dual phosphorylation at conserved threonine and tyrosine residues to be fully activated under normal physiological conditions. Thus, ERK1/2 kinase activity is often defined by the quantity of phosphorylated kinase. However, this may not accurately represent its true activity under certain pathological conditions. We investigated whether ERK1/2 kinase activity is proportional to its phosphorylation state in a rat focal ischemia model with and without rapid ischemic preconditioning. We showed that phosphorylated-ERK1/2 protein levels were increased 2.6±0.07-fold, and ERK1/2 kinase activity was increased 10.6±1.9-fold in animals receiving ischemic preconditioning alone without test ischemia compared with sham group (P<0.05, n=6/group), suggesting that phosphorylated-ERK1/2 protein levels represent its kinase activity under these conditions. However, preconditioning plus test ischemia robustly blocked ERK1/2 kinase activity, whereas it increased phosphorylated-ERK1/2 protein levels beyond those receiving test ischemia alone, suggesting that phosphorylated-ERK1/2 protein levels were not representative of actual kinase activity in this pathological condition. In conclusion, protein phosphorylation levels of ERK1/2 do not always correspond to kinase activity, thus, measuring the true kinase activity is essential. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
17. Cdk5 targets active Src for ubiquitin-dependent degradation by phosphorylating Src(S75).
- Author
-
Pan, Q., Qiao, F., Gao, C., Norman, B., Optican, L., and Zelenka, Peggy
- Subjects
- *
CYCLIN-dependent kinases , *PROTEIN-tyrosine kinases , *CELLULAR control mechanisms , *CELLULAR signal transduction , *UBIQUITIN , *PHOSPHORYLATION , *CELL adhesion - Abstract
The non-receptor tyrosine kinase Src is a critical regulator of cytoskeletal contraction, cell adhesion, and migration. In normal cells, Src activity is stringently controlled by Csk-dependent phosphorylation of Src(Y530), and by Cullin-5-dependent ubiquitinylation, which affects active Src(pY419) exclusively, leading to its degradation by the proteosome. Previous work has shown that Src activity is also limited by Cdk5, a proline-directed kinase, which has been shown to phosphorylate Src(S75). Here we show that this phosphorylation promotes the ubiquitin-dependent degradation of Src, thus restricting the availability of active Src. We demonstrate that Src(S75) phosphorylation occurs in vivo in epithelial cells, and like ubiquitinylation, is associated only with active Src. Preventing Cdk5-dependent phosphorylation of Src(S75), by site-specific mutation of S75 or by Cdk5 inhibition or suppression, increases Src(Y419) phosphorylation and kinase activity, resulting in Src-dependent cytoskeletal changes. In transfected cells, ubiquitinylation of Src(S75A) is about 35% that of wild-type Src-V5, and its half-life is approximately 2.5-fold greater. Cdk5 suppression leads to a comparable decrease in the ubiquitinylation of endogenous Src and a similar increase in Src stability. Together, these findings demonstrate that Cdk5-dependent phosphorylation of Src(S75) is a physiologically significant mechanism of regulating intracellular Src activity. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
18. Label-free electrochemical measurement of protein tyrosine kinase activity and inhibition based on electro-catalyzed tyrosine signaling
- Author
-
Yang, Yu, Guo, Liang-Hong, Qu, Na, Wei, Ming-Yuan, Zhao, Li-Xia, and Wan, Bin
- Subjects
- *
PROTEIN-tyrosine kinase inhibitors , *ELECTROCATALYSIS , *INDIUM compounds , *ELECTROCHEMICAL sensors , *PHOSPHORYLATION , *EPIDERMAL growth factor , *METALLIC surfaces - Abstract
Abstract: A novel label-free electrochemical method for measuring the activity of protein tyrosine kinases (PTK) has been developed. Epidermal growth factor receptor (EGFR), a typical PTK associated with a large percentage of all solid tumors, was used as the model kinase. Poly(glu, tyr) (4:1) peptide, as a substrate of EGFR, was covalently immobilized on the surface of indium tin oxide (ITO) electrode by silane chemistry. The tyrosine (Tyr) residue in the polypeptide served as an electrochemical signal reporter. Its voltammetric current was catalyzed by a dissolved electron mediator Os(bpy)3 2+ (bpy=2,2′-bipyridine) for increased sensitivity. Phosphorylation of the Tyr led to a loss of its electrochemical current, thus providing a sensing mechanism for PTK activity. Experimental conditions for the silanization of ITO surface and immobilization of polypeptide were investigated in details to facilitate the generation of Tyr electrochemical signal. The proposed biosensor exhibited high sensitivity and excellent stability. The limit of detection for EGFR was 1UmL−1. Furthermore, this biosensor can also be used for quantitative analysis of kinase inhibition. On the basis of the inhibitor concentration dependent electrochemical signal, the half-maximal inhibition value IC50 of three EGFR inhibitors, PD-153035, OSI-774 and ZD-1839, and their corresponding inhibition constants K i were estimated, which were in agreement with those obtained from the conventional kinase assay. This electrochemical biosensor can be implemented in an array format for the high throughput assay of in vitro PTK activity and PTK inhibitors screening for practical diagnostic application and drug discovery. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
19. The LAR protein tyrosine phosphatase enables PDGF β-receptor activation through attenuation of the c-Abl kinase activity
- Author
-
Zheng, Wei, Lennartsson, Johan, Hendriks, Wiljan, Heldin, Carl-Henrik, and Hellberg, Carina
- Subjects
- *
PROTEIN-tyrosine phosphatase , *PLATELET-derived growth factor , *LEUCOCYTES , *ANTIGENS , *FIBROBLASTS , *LABORATORY mice , *PHOSPHORYLATION , *IMMUNOBLOTTING , *SMALL interfering RNA - Abstract
Abstract: The receptor tyrosine phosphatase (RPTP) LAR negatively regulates the activity of several receptor tyrosine kinases. To investigate if LAR affects the platelet-derived growth factor (PDGF) receptor signaling, mouse embryonic fibroblasts (MEFs) from mice where the LAR phosphatase domains were deleted (LARΔP), and wt littermates, were stimulated with 20ng/ml PDGF-BB. In LAR phosphatase deficient MEFs, the phosphorylation of the PDGF β-receptor was surprisingly reduced, an event that was rescued by re-expression of wt LAR. The decreased phosphorylation of the PDGF β-receptor was observed independent of ligand concentration and occurred on all tyrosine residues, as determined by immunoblotting analysis using site-selective phosphotyrosine antibodies. This suggests that LAR is required for full PDGF β-receptor kinase activation. Downstream of receptor activation, phosphorylation of Akt and PLCγ were decreased in LARΔP MEFs, whereas Src and Erk MAP kinase pathways were less affected. The proliferation of LARΔP MEFs in response to PDGF-BB was also reduced. The inhibitory effect on the PDGF β-receptor in LARΔP cells was exerted via increased basal activity of c-Abl, since inhibition of c-Abl, by AG957 or siRNA, restored PDGF β-receptor phosphorylation. These observations suggest that LAR reduces the basal c-Abl activity thereby allowing for PDGF β-receptor kinase activation. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
20. High-Throughput Molecular Imaging for the Identification of FADD Kinase Inhibitors.
- Author
-
KHAN, AMJAD P., SCHINSKE, KATRINA A., NYATI, SHYAM, BHOJANI, MAHAVEER S., ROSS, BRIAN D., and REHEMTULLA, ALNAWAZ
- Subjects
HIGH throughput screening (Drug development) ,DEATH receptors ,APOPTOSIS ,CANCER ,PHOSPHORYLATION - Abstract
Fas-associated protein with death domain (FADD) was originally reported as a proapoptotic adaptor molecule that mediates receptor-induced apoptosis. Recent studies have revealed a potential role of FADD in NF-κB activation, embryogenesis, and cell cycle regulation and proliferation. Overexpression of FADD and its phosphorylation have been associated with the transformed phenotype in many cancers and is therefore a potential target for therapeutic intervention. In an effort to delineate signaling events that lead to FADD phosphorylation and to identify novel compounds that impinge on this pathway, the authors developed a cell-based reporter for FADD kinase activity. The reporter assay, optimized for a high-throughput screen (HTS), measures bioluminescence in response to modulation of FADD kinase activity in live cells. In addition, the potential use of the reporter cell line in the rapid evaluation of pharmacologic properties of HTS hits in mouse models has been demonstrated. (Journal of Biomolecular Screening 2010:1063-1070) [ABSTRACT FROM PUBLISHER]
- Published
- 2010
- Full Text
- View/download PDF
21. Highly sensitive detection of DNA phosphorylation by counting single nanoparticles.
- Author
-
Ma, Changbei and Yeung, Edward S.
- Subjects
- *
DNA , *PHOSPHORYLATION , *PHOSPHORYLASES , *CHEMICAL reactions , *NUCLEIC acids , *GEL electrophoresis - Abstract
DNA phosphorylation is a vital process in the repair, replication, and recombination of nucleic acids. Traditionally, it is assayed by denaturing gel electrophoresis and autoradiography, which are tedious and not sensitive. We report on the development of a sensitive, simple, and economical method for DNA phosphorylation detection and T4 polynucleotide kinase (T4 PNK) activity assay based on marking DNA phosphorylation/biotinylation events by the attachment of fluorescent nanoparticles. Enzyme activity of T4 PNK is measured down to a limit of 5 × 10−6 U/ml, which is 400 times lower than previous reports. We also studied DNA phosphorylation specificity with different DNA substrates. Furthermore, T4 PNK inhibition by the inhibitor ADP and activation by the activator spermine are shown, demonstrating the potential for high-throughput screening for inhibitors and activators. [Figure not available: see fulltext.] [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
22. Catalytically active membrane-distal phosphatase domain of receptor protein-tyrosine phosphatase α is required for Src activation.
- Author
-
Vacaru, Andrei M. and den Hertog, Jeroen
- Subjects
- *
PHOSPHATASES , *ESTERASES , *PROTEIN-tyrosine kinases , *PHOSPHORYLATION , *CHEMICAL reactions , *PROTEIN-tyrosine phosphatase - Abstract
Receptor protein-tyrosine phosphatase α (RPTPα) is a transmembrane protein with tandem cytoplasmic phosphatase domains. Most of the catalytic activity is contained by the membrane-proximal catalytic domain (D1). We found a spontaneous Arg554 to His mutation in the pTyr recognition loop of the membrane-distal phosphatase domain (D2) of a human patient. This mutation was not linked to the disease. Here, we report that the R554H mutation abolished RPTPα-D2 catalytic activity. The R554H mutation impaired Src binding to RPTPα. RPTPα, with a catalytic site cysteine to serine mutation in D2, also displayed diminished binding to Src. Concomitant with decreased Src binding of the R554H and C723S mutants compared with wild-type RPTPα, enhanced phosphorylation of the inhibitory Src Tyr527 site was observed, as well as reduced Src activation. To confirm that catalytic activity of RPTPα-D2 was required for these effects, we analyzed a third mutant, RPTPα-R729K, which had an inactive D2. Again, Src binding was reduced and Tyr527 phosphorylation was enhanced. Our results suggest that a catalytically active D2 is required for RPTPα to bind and dephosphorylate its well-characterized substrate, Src. Structured digital abstract • , , : Src (uniprotkb: ) physically interacts ( ) with RPTP alpha (uniprotkb: ) by anti bait coimmunoprecipitation ( ) [ABSTRACT FROM AUTHOR]
- Published
- 2010
- Full Text
- View/download PDF
23. PIM1 phosphorylates and negatively regulates ASK1-mediated apoptosis.
- Author
-
Gu, J. J., Wang, Z., Reeves, R., and Magnuson, N. S.
- Subjects
- *
MEDICAL research , *SERINE proteinases , *CANCER cell proliferation , *PHOSPHORYLATION , *APOPTOSIS , *OXIDATIVE stress , *CIRCULATING anticoagulants - Abstract
The serine/threonine kinase, PIM1, is involved in promoting cell survival in part by phosphorylation and inhibition of proapoptotic proteins. Apoptosis signaling kinase 1 (ASK1), a mitogen-activated protein kinase kinase kinase, is involved in the so-called stress-activated pathways that contribute to apoptotic cell death. Here we show that PIM1 phosphorylates ASK1 specifically on serine residue 83 (Ser83) both in vitro and in vivo and that PIM1 binds to ASK1 in cells by co-immunoprecipitation. Using H1299 cells, our results further demonstrate that PIM1 phosphorylation of ASK1 decreases its kinase activity induced by oxidative stress. PIM1 phosphorylation of ASK1 on Ser83 inhibited ASK1-mediated c-Jun N-terminal kinase phosphorylation as well as p38 kinase phosphorylation. Under H2O2-induced stress conditions that normally lead to apoptosis, these phosphorylation events were associated with inhibition of caspase-3 activation and resulted in reduced cell death. Moreover, knockdown of PIM1 in H1299 cells decreased phosphorylation of endogenous Ser83 of ASK1 and was associated with a decrease in cell viability after H2O2 treatment. Taken together, these data reveal a novel mechanism by which PIM1 promotes cell survival that involves negative regulation of the stress-activated kinase, ASK1. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
24. Interaction specificity of Arabidopsis 14-3-3 proteins with phototropin receptor kinases
- Author
-
Sullivan, Stuart, Thomson, Catriona E., Kaiserli, Eirini, and Christie, John M.
- Subjects
- *
PROTEIN-protein interactions , *PLANT proteins , *ARABIDOPSIS thaliana , *PROTEIN kinases , *PLANT growth , *PHOSPHORYLATION , *PHOTOCHEMISTRY - Abstract
Abstract: Phototropin receptor kinases play an important role in optimising plant growth in response to blue light. Much is known regarding their photochemical reactivity, yet little progress has been made to identify downstream signalling components. Here, we isolated several interacting proteins for Arabidopsis phototropin 1 (phot1) by yeast two-hybrid screening. These include members of the NPH3/RPT2 (NRL) protein family, proteins associated with vesicle trafficking, and the 14-3-3 lambda (λ) isoform from Arabidopsis. 14-3-3λ and phot1 were found to colocalise and interact in vivo. Moreover, 14-3-3 binding to phot1 was limited to non-epsilon 14-3-3 isoforms and was dependent on key sites of receptor autophosphorylation. No 14-3-3 binding was detected for Arabidopsis phot2, suggesting that 14-3-3 proteins are specific to phot1 signalling. Structured summary: MINT-7146953: PHOT1 (uniprotkb:O48963) physically interacts (MI:0915) with ARF7 (uniprotkb:Q9LFJ7) by two hybrid (MI:0018) MINT-7147335: PHOT1 (uniprotkb:O48963) physically interacts (MI:0914) with 14-3-3 phi (uniprotkb:P46077) by far Western blotting (MI:0047) MINT-7146854: PHOT1 (uniprotkb:O48963) physically interacts (MI:0915) with RPT2 (uniprotkb:Q682S0) by two hybrid (MI:0018) MINT-7147215: PHOT1 (uniprotkb:O48963) physically interacts (MI:0914) with 14-3-3 lambda (uniprotkb:P48349) by anti tag coimmunoprecipitation (MI:0007) MINT-7147044, MINT-7147185, MINT-7147200, MINT-7147413: PHOT1 (uniprotkb:O48963) physically interacts (MI:0914) with 14-3-3 lambda (uniprotkb:P48349) by far Western blotting (MI:0047) MINT-7146983: PHOT1 (uniprotkb:O48963) physically interacts (MI:0915) with 14-3-3 lambda (uniprotkb:P48349) by two hybrid (MI:0018) MINT-7146871: PHOT1 (uniprotkb:O48963) physically interacts (MI:0915) with NPH3-like (uniprotkb:Q9S9Q9) by two hybrid (MI:0018) MINT-7146905: PHOT1 (uniprotkb:O48963) physically interacts (MI:0915) with ARF2 (uniprotkb:Q9M1P5) by two hybrid (MI:0018) MINT-7147364: PHOT1 (uniprotkb:O48963) physically interacts (MI:0914) with 14-3-3 upsilon (uniprotkb:P42645) by far Western blotting (MI:0047) MINT-7147234: PHOT1 (uniprotkb:O48963) physically interacts (MI:0914) with 14-3-3 kappa (uniprotkb:P48348) by far Western blotting (MI:0047) [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
25. Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity.
- Author
-
Walker, M., Black, E. J., Oehler, V., Gillespie, D. A., and Scott, M. T.
- Subjects
- *
PHOSPHORYLATION , *CHEMICAL reactions , *DNA damage , *DNA replication , *ALANINE , *GENETIC mutation - Abstract
Chk1 is phosphorylated within its C-terminal regulatory domain by the upstream ATM/ATR kinases during checkpoint activation; however, how this modulates Chk1 function is poorly understood. Here, we show that Chk1 kinase activity is rapidly stimulated in a cell-cycle phase-specific manner in response to both DNA damage and replication arrest, and that the extent and duration of activation correlates closely with regulatory phosphorylation at serines (S) S317, S345 and S366. Despite their evident co-regulation, substitutions of individual Chk1 regulatory sites with alanine (A) residues have differential effects on checkpoint proficiency and kinase activation. Thus, whereas Chk1 S345 is essential for all functions tested, mutants lacking S317 or S366 retain partial proficiency for G2/M and S/M checkpoint arrests triggered by DNA damage or replication arrest. These phenotypes reflect defects in Chk1 kinase induction, as the mutants are either partially (317A and 366A) or completely (345A) resistant to kinase activation. Importantly, S345 phosphorylation is impaired in Chk1 S317A and S366A mutants, suggesting that modification of adjacent SQ sites promotes this key regulatory event. Finally, we provide biochemical evidence that Chk1 catalytic activity is stimulated by a de-repression mechanism.Oncogene (2009) 28, 2314–2323; doi:10.1038/onc.2009.102; published online 4 May 2009 [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
26. Hsp90 and a tyrosine embedded in the Hsp90 recognition loop are required for the Fer tyrosine kinase activity
- Author
-
Hikri, Elad, Shpungin, Sally, and Nir, Uri
- Subjects
- *
HEAT shock proteins , *MOLECULAR chaperones , *PROTEIN-tyrosine kinases , *MOLECULAR recognition , *PHOSPHORYLATION , *CELLULAR signal transduction , *CANCER cells - Abstract
Abstract: Hsp90 is a key regulator of tyrosine kinases activity and is therefore considered as a promising target for intervention with deregulated signaling pathways in malignant cells. Here we describe a novel Hsp90 client — the intracellular tyrosine kinase, Fer, which is subjected to a unique regulatory regime by this chaperone. Inhibition of Hsp90 activity led to proteasomal degradation of the Fer enzyme. However, circumventing the dependence of Fer accumulation on Hsp90, revealed the dependence of the Fer kinase activity and its ability to phosphorylate Stat3 on the chaperon, expressing the necessity of Hsp90 for its function. Mutation analysis unveiled a tyrosine (Tyr616) embedded in the Hsp90 recognition loop, which is required for the kinase activity of Fer. Replacement of this tyrosine by phenylalanine (Y616F) disabled the auto-phosphorylation activity of Fer and abolished its ability to phosphorylate Stat3. Notably, surrounding the replaced Y616F with subtle mutations restored the auto and trans-phosphorylation activities of Fer suggesting that Y616 is not itself an essential auto-phosphorylation site of the kinase. Taken together, our results portray Hsp90 and its recognition loop as novel positive regulators of the Fer tyrosine kinase stability and activity. [Copyright &y& Elsevier]
- Published
- 2009
- Full Text
- View/download PDF
27. Interactions between the Fyn SH3-domain and adaptor protein Cbp/PAG derived ligands, effects on kinase activity and affinity.
- Author
-
Solheim, Silje A., Petsalaki, Evangelia, Stokka, Anne J., Russell, Robert B., Taskén, Kjetil, and Berge, Torunn
- Subjects
- *
DNA-ligand interactions , *PROLINE , *PHOSPHORYLATION , *PROTEIN-protein interactions , *PROTEIN-tyrosine kinases - Abstract
Csk-binding protein/phosphoprotein associated with glycosphingolipid-enriched domains is a transmembrane adaptor protein primarily involved in negative regulation of T-cell activation by recruitment of C-terminal Src kinase (Csk), a protein tyrosine kinase which represses Src kinase activity through C-terminal phosphorylation. Recruitment of Csk occurs via SH2-domain binding to PAG pTyr317, thus, the interaction is highly dependent on phosphorylation performed by the Src family kinase Fyn, which docks onto PAG using a dual-domain binding mode involving both SH3- and SH2-domains of Fyn. In this study, we investigated Fyn SH3-domain binding to 14-mer peptide ligands derived from Cbp/PAG-enriched microdomains sequence using biochemical, biophysical and computational techniques. Interaction kinetics and dissociation constants for the various ligands were determined by SPR. The local structural impact of ligand association has been evaluated using CD, and molecular modelling has been employed to investigate details of the interactions. We show that data from these investigations correlate with functional effects of ligand binding, assessed experimentally by kinase assays using full-length PAG proteins as substrates. The presented data demonstrate a potential method for modulation of Src family kinase tyrosine phosphorylation through minor changes of the substrate SH3-interacting motif. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
28. Autophosphorylated Residues Involved in the Regulation of Human Chk2 In Vitro
- Author
-
Gabant, Guillaume, Lorphelin, Alain, Nozerand, Nathalie, Marchetti, Charles, Bellanger, Laurent, Dedieu, Alain, Quéméneur, Eric, and Alpha-Bazin, Béatrice
- Subjects
- *
PHOSPHORYLATION , *RADIOACTIVITY , *IONIZING radiation , *DNA - Abstract
Abstract: Human checkpoint kinase 2 is a major actor in checkpoint activation through phosphorylation by ataxia telangiectasia mutated in response to DNA double-strand breaks. In the absence of de novo DNA damage, its autoactivation, reported in the event of increased Cds1/checkpoint kinase 2 (Chk2) expression, has been attributed to oligomerization. Here we report a study performed on autoactivated recombinant Chk2 proteins that aims to correlate kinase activity and phosphorylation status. Using a fluorescence-based technique to assay human checkpoint kinase 2 catalytic activity, slight differences in the ability to phosphorylate Cdc25C were observed, depending on the recombinant system used. Using mass spectrometry, the phosphorylation sites were mapped to identify sites potentially involved in the kinase activity. Five phosphorylated positions, at Ser120, Ser260, Thr225, Ser379 and Ser435, were found to be common to bacteria and insect cells expression systems. They were present in addition to the six known phosphorylation sites induced by ionizing radiation (Thr68, Thr432, Thr387, Ser516, Ser33/35 and Ser19) detected by immunoblotting. After phosphatase treatment, Chk2 regained activity via autorephosphorylation. The determination of the five common sites and ionizing-radiation-inducible positions as rephosphorylated confirms that they are potential positive regulators of Chk2 kinase activity. For Escherichia coli''s most highly phosphorylated 6His-Chk2, 13 additional phosphorylation sites were assigned, including 7 novel sites on top of recently reported phosphorylation sites. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
29. Is kinase activity essential for biological functions of BRI1?
- Author
-
Weihui Xu, Juan Huang, Baohua Li, Jiayang Li, and Yonghong Wang
- Subjects
BRASSINOSTEROIDS ,PLANT hormones ,STEROIDS ,BRASSINOLIDE ,PHOSPHORYLATION - Abstract
Brassinosteroids (BRs) are a major group of plant hormones that regulate plant growth and development. BRI1, a protein localized to the plasma membrane, functions as a BR receptor and it has been proposed that its kinase activity has an essential role in BR-regulated plant growth and development. Here we report the isolation and molecular characterization of a new allele of bri1, bri1–301, which shows moderate morphological phenotypes and a reduced response to BRs under normal growth conditions. Sequence analysis identified a two-base alteration from GG to AT, resulting in a conversion of 989G to 989I in the BRI1 kinase domain. An in vitro assay of kinase activity showed that bri1-301 has no detectable autophosphorylation activity or phosphorylation activity towards the BRI1 substrates TTL and BAK1. Furthermore, our results suggest that bri1-301, even with extremely impaired kinase activity, still retains partial function in regulating plant growth and development, which raises the question of whether BRI1 kinase activity is essential for BR-mediated growth and development in higher plants.Cell Research (2008) 18:472–478. doi: 10.1038/cr.2008.36; published online 11 March 2008 [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
30. Tyr-701 is a new regulatory site for neurotrophin receptor TrkA trafficking and function.
- Author
-
de Pablo, Yolanda, Pérez-García, M. Jos, Georgieva, Maya V., Sanchis, Daniel, Lindqvist, Niclas, Soler, Rosa M., Comella, Joan X., and Llovera, Marta
- Subjects
- *
TROPOMYOSINS , *NERVE growth factor , *LIGAND binding (Biochemistry) , *TYROSINE , *PHOSPHORYLATION , *ENDOCYTOSIS - Abstract
Tropomyosin-related kinase A (TrkA) receptor mediates the effects exerted by nerve growth factor on several subpopulations of neuronal cells. Ligand binding to TrkA induces receptor autophosphorylation on several tyrosine residues and the activation of signaling cascades. In this study, we describe a new site relevant for TrkA regulation, the tyrosine 701 (Y701), which is important for receptor trafficking and activation. Y701 replacement by aspartate or phenylalanine reduces receptor internalization rate and decreases the colocalization and association of TrkA with clathrin heavy chain, demonstrating that Y701 constitutes a YxxΦ (YRKF701–704) trafficking motif relevant for the regulation of receptor endocytosis. In accordance with this hypothesis, the colocalization of Y701 mutant receptors with a lysosomal marker is also reduced giving support to the involvement of the YRKF701–704 motif in the lysosomal targeting of TrkA receptors. Contrary to what was expected, substitution of Y701 for an Asp in order to mimic phosphorylation, impairs TrkA ability to mediate nerve growth factor-induced differentiation, although the mutant receptor retains its in vitro kinase activity. This is the first evidence that a Tyr residue can simultaneously regulate TrkA receptor trafficking and activity. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
31. Characterization of the activity of human MAP kinase-interacting kinase Mnk1b
- Author
-
O’Loghlen, Ana, González, Víctor M., Jurado, Teresa, Salinas, Matilde, and Martín, M. Elena
- Subjects
- *
EUKARYOTIC cells , *PHOSPHORYLATION , *AMINO acids , *PROTEINS - Abstract
Abstract: Human mitogen-activated protein (MAP) kinase interacting kinase 1b (Mnk1b) is a splice variant of human Mnk1a, which has been identified in our laboratory [A. O’Loghlen, V.M. Gonzalez, D. Pineiro, M.I. Perez-Morgado, M. Salinas, M.E. Martin, Identification and molecular characterization of Mnk1b, a splice variant of human MAP kinase-interacting kinase Mnk1, Exp. Cell Res. 299 (2004) 343–355]. Mnk1b has much higher basal eIF4E kinase activity than Mnk1a. Because Mnk1b presents different features in its C-terminus with respect to Mnk1a, we have studied in this paper the potential role of these structural differences in determining the higher basal eIF4E kinase activity as well as the subcellular localization of Mnk1b. In this paper, we demonstrate that phosphorylation of the Thr209 and Thr214 in the activation loop of Mnk1b is necessary for its activation. However, the different kinase activity between Mnk1a and Mnk1b is independent of the phosphorylation status of the activation loop residues. By deletion of the C-terminal tail in Mnk1a, we confirmed that the absence of this sequence is not responsible for the higher eIF4E kinase activity present in Mnk1b. Moreover, our findings support a crucial role of the 12 amino acids, particularly the Ala344, in the C-terminal specific region of Mnk1b (Mnk1bSR), on the kinase activity of the protein. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
32. Regulation of IRAK-4 kinase activity via autophosphorylation within its activation loop
- Author
-
Cheng, Hong, Addona, Terri, Keshishian, Hasmik, Dahlstrand, Erik, Lu, Chafen, Dorsch, Marion, Li, Zhi, Wang, Anlai, Ocain, Timothy D., Li, Ping, Parsons, Thomas F., Jaffee, Bruce, and Xu, Yajun
- Subjects
- *
CHEMICAL reactions , *PHOSPHORYLATION , *INTERLEUKINS , *GROWTH factors - Abstract
Abstract: Interleukin-1 stimulation leads to the recruitment of MyD88, interleukin-1 receptor-associated kinase 1 (IRAK-1) and interleukin-1 receptor-associated kinase 4 (IRAK-4) to the IL-1 receptor. The formation of the IL-1 receptor complex triggers a series of IRAK-1 autophosphorylations, which result in activation. IRAK-4 is upstream of IRAK-1 and may act as IRAK-1 kinase to transmit the signal. To date, there is no upstream kinase reported for IRAK-4; the activation mechanism of IRAK-4 remains poorly understood. Here, for the first time, we report three autophosphorylation sites that are responsible for IRAK-4 kinase activity. LC–MS/MS analysis has identified phosphorylations at T342, T345, and S346, which reside within the activation loop. Site-directed mutants at these positions exhibit significant reductions in the catalytic activity of IRAK-4 (T342A: 57%; T345A: 66%; S346A: 50%). The absence of phosphorylation in kinase-dead IRAK-4 indicates that phosphorylations in the activation loop result from autophosphorylation rather than from phosphorylation by an upstream kinase. Finally, we demonstrate that autophosphorylation is an intramolecular event as wild-type IRAK-4 failed to transphosphorylate kinase-inactive IRAK-4. The present data indicate that the kinase activity of IRAK-4 is dependent on the autophosphorylations at T342, T345, and S346 in the activation loop. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
33. Gene expression analyses of ZmPti1, encoding a maize Pti-like kinase, suggest a role in stress signaling
- Author
-
Zou, Huawen, Wu, Zhongyi, Yang, Qing, Zhang, Xiuhai, Cao, Mingqing, Jia, Wensuo, Huang, Conglin, and Xiao, Xue
- Subjects
- *
GENE expression , *GENETIC regulation , *PHYSIOLOGICAL stress , *DISEASED plants - Abstract
Abstract: Pti1 plays an important role in plant disease responses. One full-length cDNA encoding a Pti1 homologue was isolated from maize by RT-PCR and named as ZmPti1. The ZmPti1 protein was expressed in Saccharomyces cereviciae, purified by ProBond Resin and examined for its autophosphorylation ability. The phosphorylation assay in vitro showed that ZmPti1 has a kinase activity. RT-PCR analysis indicated that the ZmPti1 expression is induced by salicylic acid (SA), low-temperature, mannitol and salt, but not by abscisic acid (ABA). Furthermore, in different tissues the ZmPti1 displays different expression patterns. These results demonstrate that ZmPti1 is a novel Pti1-like gene and may play multiple roles in both plant biotic and abiotic resistance pathways. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
34. Induction of apoptosis by p110C requires mitochondrial translocation of the proapoptotic BCL-2 family member BAD
- Author
-
Chen, Chen, Yan, Jun, Sun, Qing, Yao, Luyang, Jian, Yongzhi, Lu, Jieqiong, and Gu, Jianxin
- Subjects
- *
APOPTOSIS , *MITOCHONDRIA , *PHOSPHORYLATION , *CYTOCHROMES - Abstract
Abstract: p110C, a 50-kDa isoform of the PITSLRE kinase family, was demonstrated to play an important role in cell apoptosis. However, how p110C exactly promotes apoptosis is unclear. Our previous study showed that p110C interacted with p21-activated kinase 1 (PAK1), an important kinase of the proapoptotic BCL-2 family member BAD, and evidently inhibited its kinase activity. Here, we report that overexpression of p110C leads to decreased phosphorylation of BAD and its subsequent translocation from cytosol to mitochondria, which in turn induces the release of cytochrome c and the onset of apoptosis. Knocking down endogenous BAD expression will inhibit p110C induced apoptosis. Two kinase dead forms of p110C, D149N and K36N, lose the ability to inhibit the kinase activity of PAK1 and fail to induce the translocation of BAD and the BAD and such proapoptotic ability is associated with the kinase activity of p110C. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
35. Two types of calcium channels regulating activation of proline-rich tyrosine kinase 2 induced by transient brain ischemia in rat hippocampus
- Author
-
Liu, Yong, Zhang, Guang-Yi, Hou, Xiao-Yu, and Xu, Tian-Le
- Subjects
- *
TYROSINE , *PHOSPHORYLATION , *GENETIC transduction - Abstract
Tyrosine phosphorylation is an important means for regulating post-ischemic signal transduction. In this article, brain ischemia was induced by four-vessel occlusion, and the effect of ischemia/reperfusion on proline-rich tyrosine kinase 2 (Pyk2) was studied. Tyrosine phosphorylation of Pyk2 in Sprague–Dawley rat hippocampus after transient (15 min) brain ischemia and reperfusion was examined by immunoprecipitation and immunoblot. Kinase activity of Pyk2 was examined by the method of 32P-incorporation into poly(Glu-Tyr). Tyrosine phosphorylation and kinase activity of Pyk2 decreased slightly after ischemia, then increased after reperfusion and reached the peak levels (5.1 and 1.8 times the levels of the sham-operated group, respectively) at 1 h of reperfusion. Both the increases were partly inhibited by NMDA receptor antagonist ketamine and L-type voltage-gated calcium channel antagonist nifedipine administered 20 min before ischemia. The results suggested that Pyk2 was activated after transient brain ischemia and reperfusion, and it might play an important role in mediating post-ischemic signal transduction events. [Copyright &y& Elsevier]
- Published
- 2003
- Full Text
- View/download PDF
36. Activation of B‐Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601.
- Author
-
Zhang, Bao‐Hong and Guan, Kun‐Liang
- Subjects
- *
PHOSPHORYLATION , *CELL transformation , *CAENORHABDITIS elegans , *CELL differentiation , *IMMUNOBLOTTING - Abstract
The Raf kinase family serves as a central intermediate to relay signals from Ras to ERK. The precise molecular mechanism for Raf activation is still not fully understood. Here we report that phosphorylation of Thr598 and Ser601, which lie between kinase subdomains VII and VIII, is essential for B‐Raf activation by Ras. Substitution of these residues by alanine (B‐RafAA) abolished Ras‐induced B‐Raf activation without altering the association of B‐Raf with other signaling proteins. Phosphopeptide mapping and immunoblotting with phospho‐specific antibodies confirmed that Thr598 and Ser601 are in vivo phosphorylation sites induced by Ras. Furthermore, replacement of these two sites by acidic residues (B‐RafED) renders B‐Raf constitutively active. Con sistent with these data, B‐RafAA and B‐RafED exhibited diminished and enhanced ability, respectively, to stimulate ERK activation and Elk‐dependent transcription. Moreover, functional studies revealed that B‐RafED was able to promote NIH 3T3 cell transformation and PC12 cell differentiation. Since Thr598 and Ser601 are conserved in all Raf family members from Caenorhabditis elegans to mammals, we propose that phosphorylation of these two residues may be a general mechanism for Raf activation. [ABSTRACT FROM AUTHOR]
- Published
- 2000
- Full Text
- View/download PDF
37. Diurnal Patterns of Incorporation of [γP32]-ATP in Isolated Chloroplasts from G. polyedra.
- Author
-
Asano, C.S., Okamoto, O.K., and Colepicolo, P.
- Subjects
- *
ALEXANDRIUM , *CHLOROPLASTS , *PHOSPHORYLATION - Abstract
Isolated chloroplasts from the unicellular dinoflagellate Gonyaulax polyedra were obtained from cells at LD:03 and LD:15 of cell cultures conditioned to light/dark cycles of 12h/12h and 19oC temperature. Kinase activity in these organelles at different times of the day was estimated by phosphorylation experiments with radioactive labelled ATP. [γP 32]-ATP was incubated with intact organelles and the incorporation rate to proteins were estimated by autoradiography after a SDS-PAGE chromatography. Low molecular mass polypeptides were phosphorylated at night phase more intensively than in those day-is olated plastids. [ABSTRACT FROM AUTHOR]
- Published
- 1998
- Full Text
- View/download PDF
38. Isolation and characterization of a Pti1 homologue from soybean.
- Author
-
Ai-Guo Tian, Guang-Zuo Luo, Yong-Jun Wang, Jin-Song Zhang, Jun-Yi Gai, and Shou-Yi Chen
- Subjects
- *
SOYBEAN , *AMINO acid sequence , *PROTEINS , *AMINO acids , *PHOSPHORYLATION - Abstract
A full‐length gene GmPti1 was identified from soybean in an EST sequencing project by its homology to tomato Pti1. It encoded a protein of 366 amino acids. RT‐PCR analysis showed that the GmPti1 expression was induced by salicylic acid and wounding. The deduced amino acid sequence had a Ser/Thr/Tyr kinase domain. GmPti1 protein was expressed in E. coli as an MBP fusion, purified by amylose resin and examined for its autophosphorylation ability. The phosphorylation assay in vitro showed that GmPti1 had kinase activity in the presence of Mn2+. These results demonstrated that GmPti1 represented a new Pti1‐like gene, unlike the two published genes sPti1a and sPti1b, which encoding proteins had no autophosphorylation ability. [ABSTRACT FROM PUBLISHER]
- Published
- 2004
- Full Text
- View/download PDF
39. The dnaK Protein of Escherichia coli Possesses an ATPase and Autophosphorylating Activity and is Essential in an in vitro DNA Replication System
- Author
-
Zylicz, Maciej, LeBowitz, Jonathan H., McMacken, Roger, and Georgopoulos, Costa
- Published
- 1983
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.